期刊文献+

硼替佐米对急性单核细胞白血病细胞株SHI-1诱导凋亡作用及其对Bcl2l12、Bcl-2和Bax基因表达影响 被引量:2

Inducing-apoptosis Effect of Bortezomib on Acute Monocytic Leukemia Cell SHI-1 and Its Influence on Expressions of Bcl2l12,Bcl-2 and Bax Genes
下载PDF
导出
摘要 本研究探讨蛋白酶抑制剂硼替佐米对急性单核细胞白血病细胞株SHI-1增殖和凋亡的影响及Bcl2l12、Bcl-2和Bax基因在其中的作用。用MTT比色法观察硼替佐米对SHI-1细胞的生长抑制作用,用Annexin-V标记、线粒体跨膜电位(Δψm)和DNA凝胶电泳分析细胞凋亡,用RT-PCR方法检测0、6,12和24小时Bcl2l12、Bcl-2和Bax基因表达。结果表明,硼替佐米呈时间和剂量依赖性抑制SHI-1细胞生长,24小时和48小时半数抑制浓度分别为54.13 nmol/L和5.45 nmol/L;硼替佐米能够诱导SHI-1细胞凋亡,在6小时Annexin-V阳性细胞就开始增高并呈时间依赖性,Δψm减低,形态学可见明显细胞核凝聚、固缩和碎裂,DNA凝胶电泳显示DNA片段化;RT-PCR显示,Bcl2l12表达增高,Bcl-2表达减低,但Bax表达无明显改变。结论:硼替佐米抑制SHI-1细胞增殖,并可能通过上调Bcl2l12基因和下调Bcl-2基因,使线粒体膜电位下降而促使SHI-1细胞发生凋亡。 Abstract This study was aimed to explore the effect of bortezomib on proliferation and apoptosis of acute monocytic leukemic cells SHI-1 and the function of Bcl-2 gene family including Bc12112, Bcl-2 and Bax in its apoptosis. SHI-1 cells were cultured and treated with bonezomib of different concentrations for different time. MTT assay was used to de- tect the proliferation and apoptosis, Annexin-V staining, mitochondrial transmembrane potential (A0m) and DNA aga- rose gel eleetrophoresis were used to investigate apoptosis of SHI-1 cells. RT-PCR was used to analyze the levels of Bc12112, Bcl-2 and bax mRNA in SHI-1 cells treated with bortezomib for 0,6,12 and 24 hours. The results showed that bortezomib inhibited the proliferation of SHI-1 ceils in time-and doze-dependent manners, the IC50 at 24 and 48 hours were 54.13 nmol/L and 5.45 nmol/L respectively. Bortezomib could induce apoptosis of SHI-1 cells in time-dependent manner, increase expression of Annexin-V positive cells, deerease A0m of SHI-1 cells and result in DNA fragmention and morphologic changes of apoptosis. RT-PCR showed that Bc12112 mRNA expression was up-regulated, bcl-2 mRNA expression was down-regulated and bax mRNA expression was not changed obviously. It is concluded that bortezomib inhibits the proliferation of SHI-1 and induces apoptosis in which Bc12112 and Bcl-2 gene can be ones of the main genes taking part in.
出处 《中国实验血液学杂志》 CAS CSCD 2008年第5期1016-1020,共5页 Journal of Experimental Hematology
基金 宁波市医学科技计划项目资助(编号200520) 宁波市干细胞移植重点实验室资金资助(编号2006A62003)
关键词 硼替佐米 SHI—1细胞 细胞凋亡 Bcl2112基因 BCL-2基因 BAX基因 急性单核细胞白血病 Bortezomib SHI-1 cells apoptosis Bcl2112 gene Bcl-2 gene Bax gene
  • 相关文献

参考文献11

  • 1陈苏宁,薛永权,张学光,吴亚芳,潘金兰,王勇,岑建农.一株伴有t(6;11)(q27;q23)和p53基因异常的人单核细胞白血病细胞系SHI-1的建立及鉴定[J].中华血液学杂志,2005,26(2):94-99. 被引量:17
  • 2陈丽娟,李建勇,钱思轩,朱广荣,郑文娟.Velcade诱导多发性骨髓瘤细胞株U266细胞凋亡研究[J].中国实验血液学杂志,2006,14(4):696-699. 被引量:4
  • 3Aghajanian C, Dizon DS, Sabbatini P, et al. Phase I trial of borte- zomib and carboplatin in recurrent ovarian or primary peritoneal cancer. J Clin Oneol, 2005; 23:5943 -5949 被引量:1
  • 4Dreicer R, Petrylak D, Agus D, et al. Phase 1/11 study of bortezomib plus docetaxel in patients with advanced androgen-independent prostate cancer. 2007 ; 13 : 1208 - 1215 被引量:1
  • 5Cortes J, Thomas D, KoUer C, et al. Phase I study of bortezomib in refractory or relapsed acute leukemias. Clin Cancer Res, 2004; 10: 3371 - 3376 被引量:1
  • 6孙启鑫,孟凡义,扶云碧,李利.硼替佐米单用或联合三尖杉酯碱体外诱导HL-60细胞凋亡实验研究[J].中国实验血液学杂志,2007,15(2):233-236. 被引量:15
  • 7Bomer C. The Bcl-2 protein family : sensors and checkpoints for life- or-death decisions. Mol Immunol, 2003; 39:615 -647 被引量:1
  • 8Oltvai ZN, Milliman CL, Korsmeyer SJ. Bel-2 heterodimefizes/n vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell, 1993; 74:609-619 被引量:1
  • 9Scorilas A, Kyriakopoulou L, Yousef GM, et al. Molecular cloning, physical mapping, and expression analysis of a novel gene, BCL2L12, encoding a proline-rich protein with a highly conserved BH2 domain of the Bcl-2 family. Genomics, 2001 ; 72:217 -221 被引量:1
  • 10Floros KV, Thomadaki H, Lallas G, et 02. Cisplatin-induced apoptosis in HL-60 human promyeloeytic leukemia cells: differential expression of BCL2 and novel apoptosis-related gene BCL2L12. Ann N Y Acad Sci, 2003 ; 1010 : 153 - 158 被引量:1

二级参考文献35

  • 1周永列,吕亚萍,邱莲女,王文松,林惠君.硝普钠诱导K562细胞凋亡机制的研究[J].中国实验血液学杂志,2005,13(6):983-988. 被引量:5
  • 2薛永权 过宇.介绍一种改良的骨髓细胞染色体热变性姬姆萨R显带法[J].中华医学检验杂志,1986,9:247-247. 被引量:25
  • 3Drexler HG, Matsuo Y, Macleod RAF. Continuous hematopoietic cell lines as model systems for leukemia-lymphoma research. Leuk Res,2000, 24:881-911. 被引量:1
  • 4Mitterbauer G, Zimmer C, Fonatseh C, et al. Monitoring of minimal residual disease in patients with MLL-AF6-positive acute myeloid leukemia by RT-PCR. Leukemia, 1999,13:1519-1524. 被引量:1
  • 5Nollet F, Billiet J, Selleslag D, et al. Standardization of multiplex fluorescent short tandem repeat analysis for chimerism testing. Born, Marros Transplant,2001 ,28:511-518. 被引量:1
  • 6Drexler HG, F6mbonne S, Matsuo Y, et al. p53 alterations in human leukemia-lymphoma cell lines: in vitroariifaet or prerequisite for cell immortalization? Leukemia,2000, 14 : 198-206. 被引量:1
  • 7Uphoff CC, Drexler HG. Detection of mycoplasma in leukemialymphoma cell lines using pnlymerase chain reaction. Leukemia, 2002,16: 289-293. 被引量:1
  • 8Drexler HG,Dirks WG, Matsuo Y, et al. False letzkemia-lymphoma cell lines: an update on over 500 cell lines, Leukemia,2003, 17:416-426. 被引量:1
  • 9Drexler HG, Matsuo Y. Guidelines for the charaetelization and publieatinn of human malignant hematupoietie cell lines. Leukemia,1999, 13:835-842. 被引量:1
  • 10Kubota K, Preislef HD, Lok MS, et al. Lack of effect of eolonystimulating activity on human mveloid leukemia cell line ( ML2 )cells, Leuk Res,1981, 5:311-320. 被引量:1

共引文献31

同被引文献1

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部